Immunohistochemistry (IHC) performed with human PCa samples revealed that the expression level of p300 protein clearly correlated with the level of the AR protein and that prostate-specific ablation of p300 decreased prostate cancer cell proliferation and tumor growth in the PTEN knockout mouse model, which resulted in an increased survival rate of these mice. The gene discussed is EP300; the disease is prostate carcinoma.